rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    REGN
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      US FDA approves Regeneron's drug for generalized myasthenia gravis
      5h agoReutersREGN
      Regeneron Wins EC Clearance for Libtayo Dosing Flexibility
      10h agoYahoo FinanceREGN
      Does Flexible Libtayo Dosing Change The Bull Case For Regeneron Pharmaceuticals Stock?
      21h agoYahoo FinanceREGN
      Regeneron Pharmaceuticals (REGN), Why Is The Market Taking A Closer Look?
      22h agoYahoo FinanceREGN
      CytomX to receive $5M from Regeneron for cancer drug milestone (CTMX:NASDAQ)
      Nov 18Seeking AlphaCTMXREGN
      Biotechnology Market Companies 2027 Analysis: Amgen, Gilead, Regeneron, Vertex and Moderna Post Strong 2026 Results as Billion-Dollar Deals Reshape a Market Headed for USD 6.34 Trillion by 2035
      Nov 17Yahoo FinanceAMGNGILDMRNAREGN
      Can Regeneron Stock Hit $1,400?
      Nov 17Yahoo FinanceREGN
      European Commission approves flexible dosing for Regeneron’s Libtayo
      Nov 17Investing.comREGN
      Regeneron Has $16 Billion in Net Cash and Trades Near 20 Times Earnings. Is It the Cheapest Big Biotech? | The Motley Fool

      The stock has climbed more than 40% in one year.

      Nov 14The Motley FoolREGN
      Regeneron Drug Lowers Standing Heart Rate And Improves Symptoms In Heart Disease Study
      Nov 13BenzingaREGN
      If You Invested $1000 In Regeneron Pharmaceuticals Stock 15 Years Ago, You Would Have This Much Today
      Nov 12BenzingaREGN
      REGN Soars 27.4% in a Month: Buy, Sell or Hold the Stock?
      Nov 12Yahoo FinanceREGN
      Jefferies reiterates Regeneron stock rating ahead of patent hearing
      Nov 11Investing.comREGN
      Amgen vs. Regeneron: Higher Dividends Now or Bigger Growth Later?
      Nov 10Yahoo FinanceAMGNREGN
      Regeneron Pharmaceuticals Advances Liver Drug After Early Trial Cuts Liver Fat by Up to 80%
      Nov 10Yahoo FinanceREGN
      Alnylam Collaborator Regeneron Advances CIDEBsiRNA with Promising First-in-Human Results in Patients with MASLD

      CAMBRIDGE, Mass., November 10, 2026--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that its collaborator, Regeneron Pharmaceuticals, Inc. shared initial results from a first-in-human trial that demonstrated a single subcutaneous dose of CIDEBsiRNA (previously known as ALN-CIDEB) rapidly normalized liver fat and improved liver injury markers in patients with metabolic-dysfunction-associated steatotic liver disease (MASLD) with effects that we

      Nov 10Yahoo FinanceALNYREGN
      The Top 5 Biotech Stocks I'd Buy Right Now Without Any Hesitation

      Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

      Nov 8The Globe and MailREGN
      Regeneron Pharmaceuticals (REGN) Extends BARDA Deal As Libtayo Long Term Data Holds Up
      Nov 8Yahoo FinanceREGN
      Huda Y Zoghbi At Regeneron Pharmaceuticals Executes Options Exercise, Realizing $3.88M
      Nov 6BenzingaREGN
      Mary Tyler Moore Vision Initiative Welcomes Regeneron and Adaptive Sensory Technology to Its Consortium

      The Mary Tyler Moore Vision Initiative (MTM Vision) today announced that Regeneron Pharmaceuticals, Inc. has joined the MTM Vision Consortium as a founding member and Adaptive Sensory Technology as a device company member.

      Nov 5Yahoo FinanceREGN
      Strategic Exercise: Christine A Poon Decides To Exercise Options Worth $4.39M At Regeneron Pharmaceutical
      Nov 5BenzingaREGN
      At Regeneron Pharmaceuticals, George L Sing Chooses To Exercise Options, Resulting In $8.53M
      Nov 5BenzingaREGN
      Regeneron director George Sing sells $20.3M in shares after option exercise
      Nov 5Investing.comREGN
      Regeneron director George Sing sells $20.3 million in stock
      Nov 5Investing.comREGN
      Is Regeneron Stock Riskier Than It Looks?
      Nov 5Yahoo FinanceREGN
      Is Regeneron Stock Increasing Your Market Risk?
      Nov 4Yahoo FinanceREGN
      Regeneron director Christine Poon sells $7.59M in stock
      Nov 4Investing.comREGN
      Regeneron Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors
      Nov 4MarketWatchREGN
      Was There Any Sign Regeneron Stock Would Run?
      Nov 4Yahoo FinanceREGN
      Why Regeneron (REGN) Might be Well Poised for a Surge
      Nov 4Yahoo FinanceREGN
      Regeneron (REGN) Receives a Rating Update from a Top Analyst

      Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

      Nov 3The Globe and MailREGN
      UnitedHealth, Cleveland-Cliffs, Regeneron Pharmaceuticals And More: CNBC’s ‘Final Trades’
      Nov 3BenzingaREGNCLFUNHRSP
      REGN Q3 deep dive: pipeline progress and core brands drive outperformance
      Nov 2Yahoo FinanceREGN
      Regeneron's 'Strong Commercial' Q3 Underscores Core Business Health, RBC Capital Markets Says
      Nov 2Yahoo FinanceREGN
      Cantor Fitzgerald raises Regeneron stock price target on Dupixent strength
      Nov 2Investing.comREGN
      Why is Regeneron Pharmaceuticals stock surging today?
      Nov 2Investing.comREGN
      Truist raises Regeneron stock price target to $982 on strong results
      Nov 2Investing.comREGN
      These Analysts Raise Their Forecasts On Regeneron Pharmaceuticals After Upbeat Q3 Results
      Nov 2BenzingaREGN
      Earnings roundup: AstraZeneca’s cost cuts, Alnylam’s slump and Regeneron’s resilience
      Nov 2Yahoo FinanceALNYAZNREGN
      The top 5 analyst questions from Regeneron’s Q3 earnings call
      Nov 2Yahoo FinanceREGN
      Top 3 Health Care Stocks That May Fall Off A Cliff This Quarter
      Nov 2BenzingaEXELREGN
      Regeneron Pharmaceuticals To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Monday
      Nov 2BenzingaNRXPREGN
      BofA raises Regeneron stock price target on strong revenue beat
      Nov 2Investing.comREGN
      FDA Decision Watch: Regeneron And Roche’s Autoimmune Drugs, Capricor’s DMD Therapy In Spotlight
      Nov 2Yahoo FinanceALNYCAPRREGN
      Wells Fargo raises Regeneron stock price target to $925 on execution
      Nov 2Investing.comREGN
      Guggenheim raises Regeneron stock price target to $1,100 on strong Q3 results
      Nov 2Investing.comREGN
      Regeneron Q3 2026 slides: record results, $8B Sanofi alliance
      Nov 1Investing.comREGNSNY
      Earnings call transcript: Regeneron beats Q3 2026 estimates, shares jump 13%
      Nov 1Investing.comREGN
      The top 5 analyst questions from Regeneron’s Q3 earnings call

      Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

      Nov 1The Globe and MailREGN
      Regeneron (REGN) Stock Looks At A Discount To Earnings
      Oct 31Yahoo FinanceREGN

      This is the newest page. Registered accounts read further back.